Impact of pre-analytical variables in the determination of serum galactomannan
- 12 November 2016
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 55 (6) , myw123-641
Abstract
Invasive aspergillosis (IA) is associated with a high morbidity and mortality. Since Aspergillus species are usually not cultured in these patients, presumptive diagnosis of IA is more commonly based on galactomannan (GM) detection. Several factors are known to cause false-positive results in the GM test, but little is known on the influence of pre-analytical variables interfering on the test. Here we studied the influence of temperature and sample storage duration in GM results, using samples known to be negative and positive (spiked) for GM. We also evaluated the effect of hemolysis and hyperbilirubinemia on GM optical indexes. We found no influence of storage time (up to 96 h) and temperatures (refrigerated vs. RT) on GM results. However, bilirubin (P = .022) and haemoglobin (P = .003) content influenced GM readings in samples known for being GM positive and negative at baseline, respectively. We conclude that the Platelia GM test does not suffer major influence of pre-analytical variables such as storage conditions, and low levels of hemolysis and hyperbilirubinemia. Nonetheless, massive haemolysis seems to interfere with GM readings in GM-negative samples, and high levels of bilirubin can affect GM readings in samples that are positive for GM at baseline. These findings may facilitate logistics and the implementation of standard operational procedures in clinical laboratories.Keywords
This publication has 20 references indexed in Scilit:
- Combination Antifungal Therapy for Invasive AspergillosisAnnals of Internal Medicine, 2015
- Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United StatesJournal of Clinical Microbiology, 2014
- Lack of intra‐laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigenTransplant Infectious Disease, 2011
- Invasive Aspergillosis in the Intensive Care UnitClinical Infectious Diseases, 2007
- Update on the contribution of galactomannan for the diagnosis of invasive aspergillosisMycopathologia, 2007
- The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma HemoglobinJAMA, 2005
- Influence of short-term venous stasis on clinical chemistry testingClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosisThe Lancet Infectious Diseases, 2004
- Hemolysis in Serum Samples Drawn by Emergency Department Personnel versus Laboratory PhlebotomistsLaboratory Medicine, 2002
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000